Tag: MENA

Explore all our news . .

Recent Posts

CCOI DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cogent Communications Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CCOI

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cogent Communications Holdings, Inc. (NASDAQ: CCOI) between February 29, 2024 and May 1, 2026, inclusive (the “Class Period”), of the important September 21, 2026 lead plaintiff

MVST DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Microvast Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MVST

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Microvast Holdings, Inc. (NASDAQ: MVST) between April 1, 2025 and March 16, 2026, inclusive (the “Class Period”), of the important September 21, 2026 lead plaintiff deadline. SO

PLAB DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Photronics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 4 Deadline in Securities Class Action – PLAB

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Photronics, Inc. (NASDAQ: PLAB) between December 10, 2025 and May 27, 2026, inclusive (the “Class Period”), of the important September 4, 2026 lead plaintiff deadline. SO WHAT:

PLAB DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Photronics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 4 Deadline in Securities Class Action – PLAB

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Photronics, Inc. (NASDAQ: PLAB) between December 10, 2025 and May 27, 2026, inclusive (the “Class Period”), of the important September 4, 2026 lead plaintiff deadline. SO WHAT:

Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership and high-growth markets Highlights Fortrea enters into a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials Includes a 60,000 sq. ft.